Correlation between peripheral blood CD4+CD25high CD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphoma

Chinese Journal of Cancer

Volumn 28, Issue 11, 2009, Pages 59-64

  Lin, Hui ^a   Sun, Xiao Fei ^a   Zhen, Zi Jun ^a   Xia, Yi ^a   Ling, Jia Yu ^a   Huang, Hui Qiang ^a   Xia, Zhong Jun ^a   Lin, Tong Yu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

CD127low Treg; Clinical characteristic; Non Hodgkin's lymphoma

Indexed keywords

CD4 ANTIGEN; FLUOROCHROME; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; B CELL LYMPHOMA; BLOOD LEVEL; CANCER STAGING; CD127 LYMPHOCYTE COUNT; CD127+ T LYMPHOCYTE; CD25 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CHILD; CHINA; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SEX DIFFERENCE; T LYMPHOCYTE; UNIVERSITY HOSPITAL;

EID: 79955868944     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10180     Document Type: Article

References (31)

1. Shen ZX, Zhu XZ. Malignant lymphoma [M]. Beijing: People Health Publishing Company, 2003:43. [in Chinese]
2. Gatti RA, Good RA. Occurrence of malignancy in immunodeficiency diseases. A literature review [J]. Cancer, 1971,28 (1):89-98.
3. Hoshida Y, Tsukuma H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan [J]. Int J Cancer, 1997, 71 (4):517-520.
4. + regulatory T cells: their common role in contr olling autoimmunity, tumor immunity, and transplantation tolerance [J]. Immunol Rev, 2001,182: 18-32.
5. + regulatory T cells in autoimmune diseases [J]. Nat Cli n Pract Rheumatol, 2007, 3(11):619-626.
6. Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [J]. Clin Cancer Res, 2003, 9(2): 606-612.
7. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a sing le mechanism of self-tolerance causes various autoimmune diseases [J]. J Immunol, 1995, 155 (3): 1151-1164.
8. + T reg cells [J]. J Exp Med, 2006, 203(7): 1701-1711.
9. Hori S, Nomura T, Sakaguchi S. Control of reg ulatory T cell development by the transcription factor Foxp3 [J]. Science. 2003, 299 (5609):1057-1061.
10. Fontenot JD, Rudensky AY. A well adapted reg ulatory contrivance: regu latory T cell development and the forkhead family tra nscription factor Foxp3 [J]. Nat Immunol, 2005, 6(4):331-337.
11. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL) -2 and IL-7 receptors discriminates between human regu latory and activated T cells [J]. J Exp Med, 2006, 203 (7): 1693-1700.
12. Fujimoto S, Greene M, Sehon AH. Immunosuppressor T cells in tumor bearing host [J], lmmunol Commun, 1975, 4(3):201-217.
13. Ghiringhelli F, Menard C, Martin F, et al. The role of reg ulatory T cells in the contro l of natural killer cells: relevance during tumor progression [J], Immunol Rev, 2006, 214: 229-238.
14. Ménard C, Martin F, Apetoh L, et al. Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity [J], Cancer Immunol lm munother, 2008,57 (11):1579-1587.
15. + regulatory T cell population by non -Hodgkin's lymphoma [J]. Blood, 2008,111 (11): 5359-5370.
16. 4 regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymph oma, follicular lymphoma and classical Hod gkin's lymphoma [J]. Haematologica, 2008, 93 (2): 193-200.
17. + cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression [J]. Am J Clin Pathol, 2007,128 (6):958-965.
18. + regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival [J]. Leukemia, 2007, 21 (12):2512-2518.
19. Carreras J, Lopez-Guillermo A, Fox BC, et al. High numbers of tumor- infiltra t ing FOXP3-positive regu latory T cells are associated with improved overall survival in follicular lymphoma [J]. Blood, 2006, 108 (9):2957-2964.
20. + T cells in B-cell non -Hod gkin lymphoma [J]. Blood. 2006, 107(9):3639-3646.
21. Lee NR, Song EK, Jang KY, et al. Prognostic impact of tumor infiltrating FOXP3 positive reg ulatory T cells in diffuse large B-cell lymphoma at diagnosis [J]. Leuk Lymphoma, 2008,49 (2):247-256.
22. + regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells [J]. J Im munol Methods, 2007,319(1-2):41-52.
23. lo regulatory T lymphocytes from the peripheral blood in Chinese healthy individuals [J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2007,23 (9):816-818. [in Chinese]
24. lo/- T cells in gastric cancer patients and its significance [J]. Xian Dai Yi Yao Wei Sheng, 2007,23(17):2537-2539. [in Chinese]
25. high regulatory T cells in peripheral blood of patients with B cell non-Hodgkin's lymphoma [J]. J Clin Exp Hematop, 2006,14(1):119-122. [in Chinese]
26. De Stefani E, Fierro L, Barrios E, et al. Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case-control study in Uruguay [J]. Leuk Res, 1998, 22 (5):445-452.
27. Nieters A, Rohrmann S, Becker N, et al. Smoking and lymphoma risk in the Eu ropean prospective investigation into cancer and nutrition [J]. Am J Epidemiol, 2008, 167 (9):1081-1089.
28. + T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma mode l [J]. J Immunol, 2007,178 (11):6840-6848.
29. Onizuka S, Tawara I, Shimizu J, et al. Tumor rejection by in vivo administrat ion of anti-CD25 (inter leukin- 2 receptor alpha) monoclonal antibody [J]. Cancer Res, 1999, 59 (13):3128-3133.
30. Foss FM. DAB (389) IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma [J]. Clin Lymphoma, 2000, 1(2): 110-116.
31. Frankel AE, Powell BL, Lilly MB. Diphtheria toxin conjugate therapy of cancer [J]. Cancer Chemother Biol Response Modif, 2002, 20:301-313